Department of Pediatric Endocrinology, Dr. von Hauner Children's Hospital, LMU-University of Munich, Munich, Germany.
Institute for Medical Information Processing, Biometry and Epidemiology, Faculty of Medicine, LMU-University of Munich, Munich, Germany.
J Bone Miner Res. 2024 Aug 21;39(8):1094-1102. doi: 10.1093/jbmr/zjae092.
Nephropathic cystinosis is an orphan autosomal recessive lysosomal storage disease characterized by a deficiency of cystinosin, a cystine transporter protein, leading to tissue damage, primarily in the kidney and cornea. With the introduction of cystine-depleting therapy with cysteamine and the possibility to survive to adulthood, new challenges of skeletal complications are a concern, with sparse data available regarding bone development. The aim of the current study was to gain more information on bone density and geometry in these patients. Fifty-one patients (29 males, 22 females) with genetically proven nephropathic cystinosis were clinically evaluated with a medical history, physical examination, grip strength measurements, and biochemical and imaging studies. Bone mineral density, bone geometry, and muscle cross sectional area were measured, and muscle was evaluated. Results were compared with age- and gender-specific reference data. Z-scores for height (mean [M] = -1.75, standard deviation [SD] = 1.43), weight (M = -1.67, SD = 1.29), and BMI (M = -0.98, SD = 1.29) were lower than reference data. Medullary cross-sectional area (CSA) and cortical density z-scores were not compromised (M = 0.12, SD = 1.56 and M = -0.25, SD = 1.63, respectively), but cortical CSA z-scores and Strength-Strain Index (SSI) were reduced (M = -2.16, SD = 1.08, M = -2.07, SD = 1.08). Muscular deficits were reflected by reduced z-scores for muscle CSA (M = -2.43, SD = 1.27) and grip strength (M = -3.01, SD = 1.10), along with jump force (34% lower than reference value). Multiple regression analyses indicated an association of muscle mass with medullary CSA and SSI, but not with cortical CSA. While bone density parameters were normal, bone geometry was altered, resulting in a thinner cortex with possible impact on bone strength. Muscle weakness be partially responsible for altered bone geometry and could provide a potential treatment target.
遗传性胱氨酸贮积症是一种常染色体隐性溶酶体贮积病,其特征为半胱氨酸转运蛋白胱氨酸酶缺乏,导致组织损伤,主要发生在肾脏和角膜。随着半胱胺耗竭疗法的引入以及成年后存活的可能性,骨骼并发症的新挑战受到关注,而关于骨骼发育的稀疏数据可用。本研究的目的是获得更多关于这些患者骨密度和骨几何结构的信息。51 名(29 名男性,22 名女性)遗传性胱氨酸贮积症患者进行了临床评估,包括病史、体格检查、握力测量以及生化和影像学研究。测量了骨矿物质密度、骨几何结构和肌肉横截面积,并评估了肌肉。将结果与年龄和性别特异性参考数据进行比较。身高(均值[M] =-1.75,标准差[SD] =1.43)、体重(M =-1.67,SD =1.29)和 BMI(M =-0.98,SD =1.29)的 Z 分数均低于参考数据。骨髓横截面积(CSA)和皮质密度 Z 分数未受损(M =0.12,SD =1.56 和 M =-0.25,SD =1.63),但皮质 CSA Z 分数和强度-应变指数(SSI)降低(M =-2.16,SD =1.08,M =-2.07,SD =1.08)。肌肉缺陷反映在肌肉 CSA(M =-2.43,SD =1.27)和握力(M =-3.01,SD =1.10)的 Z 分数降低,以及跳跃力(比参考值低 34%)。多元回归分析表明,肌肉质量与骨髓 CSA 和 SSI 相关,但与皮质 CSA 无关。虽然骨密度参数正常,但骨几何结构发生改变,导致皮质变薄,可能对骨强度产生影响。肌肉无力可能部分导致骨几何结构改变,并可能为潜在的治疗靶点提供依据。